Batu Biologics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Crowdfunding

  • Latest Deal Amount
  • $1.65M

  • Investors
  • 1

Batu Biologics General Information

Description

Developer of allogeneic cell therapies designed to create and break immune tolerance. The company offers an allogeneic and universal donor cellular vaccine to stimulate a targeted immune response against the blood vessels of the tumor for an array of cancers, enabling patients to recover from cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • 9255 Towne Centre Drive
  • Suite 450
  • San Diego, CA 92121
  • United States
+1 (213) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Batu Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Equity Crowdfunding 25-Dec-2017 $1.65M 00.000 Completed Generating Revenue
5. Angel (individual) 10-May-2017 00000 00.000 Completed Generating Revenue
4. Angel (individual) 29-Jan-2016 00.000 00.000 Completed Generating Revenue
3. Angel (individual) 26-Nov-2014 00000 00000 Completed Generating Revenue
2. Product Crowdfunding 17-Aug-2014 $100K Completed Generating Revenue
1. Spin-Off 01-Dec-2013 Completed Startup
To view Batu Biologics’s complete valuation and funding history, request access »

Batu Biologics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of allogeneic cell therapies designed to create and break immune tolerance. The company offers an allogeneic a
Drug Discovery
San Diego, CA
4 As of 2024
00.000
000000000000 00.000

000000

eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim ven
000000000000000
Wilmington, DE
0000 As of 0000
00000000000

00 000

nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
0000 000000000
Irvine, CA
00 As of 0000
00000
0.000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Batu Biologics Competitors (135)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Incyte Formerly VC-backed Wilmington, DE 0000 00000000000
CG Oncology Formerly VC-backed Irvine, CA 00 00000 00000000 00000
Regulus Therapeutics Formerly VC-backed San Diego, CA 00 00000 000000000 00000
Poseida Therapeutics Formerly VC-backed San Diego, CA 000 00000 00000000000 00000
Achaogen Formerly VC-backed South San Francisco, CA 00 00000 0000000000.
You’re viewing 5 of 135 competitors. Get the full list »

Batu Biologics Patents

Batu Biologics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200297829-A1 Integrative immunotherapy for cancer treatment Inactive 18-Mar-2019 000000000
US-20190282641-A1 Generation of tumor endothelium specific viruses Inactive 16-Mar-2018 0000000000
US-20190255127-A1 Augmentation of oncolytic viral efficacy through immunological targeting tumor endothelial cells Inactive 21-Feb-2018 000000000
US-20190239937-A1 Augmentation of abscopal effect of cryotherapy and other tumor cell death by anti-angiogenic and anti-tumor vaccination Inactive 02-Feb-2018 000000000
US-20190224292-A1 Methods of augmenting tumor vaccine efficacy through endothelial targeting Inactive 22-Jan-2018 A61K39/001102
To view Batu Biologics’s complete patent history, request access »

Batu Biologics Executive Team (6)

Name Title Board Seat Contact Info
Thomas Ichim Ph.D Co-Founder, Chief Executive Officer, Chief Scientific Officer, President & Board Member
Gerry Berg Chief Financial Officer
Hong Ma Ph.D Board Member & Vice President of Business Development
Alan Lewis Ph.D Co-Founder & Chairman
You’re viewing 4 of 6 executive team members. Get the full list »

Batu Biologics Board Members (6)

Name Representing Role Since
Alan Lewis Ph.D Self Co-Founder & Chairman 000 0000
Hong Ma Ph.D Batu Biologics Board Member & Vice President of Business Development 000 0000
John Chiplin Ph.D Self Board Member 000 0000
Vladimir Bogin MD Self Board Member 000 0000
You’re viewing 4 of 6 board members. Get the full list »

Batu Biologics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Batu Biologics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Joseph Peck Angel (individual) Minority 000 0000 000000 0
To view Batu Biologics’s complete investors history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »